Below are the most recent publications written about "Neuroimaging" by people in Profiles.
-
Smith KM, Saranathan M. Imaging in Movement Disorders: A Clinician's Perspective on Novel Applications. Semin Neurol. 2025 Dec; 45(6):690-698.
-
Saranathan M, Cogliandro G, Hicks T, Patterson D, Vachha B, Hader A, Shazeeb MS, Cacciola A. Comprehensive Segmentation of Deep Grey Nuclei From Structural MRI Data. Hum Brain Mapp. 2025 Oct 01; 46(14):e70350.
-
Bu XL, Zhu W, Wang QH, Liu ZT, Bao YY, Bai YD, Li JH, Liu ZH, Zhao JL, Xiang Y, Jin WS, Wang J, Lei X, Wang YJ. Association between self-reported multimorbidity and longitudinal brain A? deposition in Alzheimer's disease. Nat Commun. 2025 Jul 01; 16(1):5905.
-
Lowenthal JM, Choi D, Dundamadappa SK. Applications of spectral CT in emergency department imaging, with a focus on neuroimaging. Emerg Radiol. 2025 Aug; 32(4):591-604.
-
Sprague DY, Rusch K, Dunn RL, Borchardt JM, Ban S, Bubnis G, Chiu GC, Wen C, Suzuki R, Chaudhary S, Lee HJ, Yu Z, Dichter B, Ly R, Onami S, Lu H, Kimura KD, Yemini E, Kato S. Unifying community whole-brain imaging datasets enables robust neuron identification and reveals determinants of neuron position in C.?elegans. Cell Rep Methods. 2025 Jan 27; 5(1):100964.
-
Weiner MW, Kanoria S, Miller MJ, Aisen PS, Beckett LA, Conti C, Diaz A, Flenniken D, Green RC, Harvey DJ, Jack CR, Jagust W, Lee EB, Morris JC, Nho K, Nosheny R, Okonkwo OC, Perrin RJ, Petersen RC, Rivera-Mindt M, Saykin AJ, Shaw LM, Toga AW, Tosun D, Veitch DP. Overview of Alzheimer's Disease Neuroimaging Initiative and future clinical trials. Alzheimers Dement. 2025 Jan; 21(1):e14321.
-
Shaw LM, Korecka M, Lee EB, Cousins KAQ, Vanderstichele H, Schindler SE, Tosun D, DeMarco ML, Brylska M, Wan Y, Burnham S, Sciulli A, Vulaj A, Tropea TF, Chen-Plotkin A, Wolk DA. ADNI Biomarker Core: A review of progress since 2004 and future challenges. Alzheimers Dement. 2025 Jan; 21(1):e14264.
-
Daci R, Gray-Edwards H, Shazeeb MS, Vardar Z, Vachha B, Cataltepe OI, Flotte TR. Neuroimaging Applications for the Delivery and Monitoring of Gene Therapy for Central Nervous System Diseases. Hum Gene Ther. 2024 Nov; 35(21-22):886-895.
-
Tosun D, Hausle Z, Thropp P, Concha-Marambio L, Lamoureux J, Lebovitz R, Shaw LM, Singleton AB, Weiner MW, Blauwendraat C. Association of CSF a-synuclein seed amplification assay positivity with disease progression and cognitive decline: A longitudinal Alzheimer's Disease Neuroimaging Initiative study. Alzheimers Dement. 2024 12; 20(12):8444-8460.
-
Segobin S, Haast RAM, Kumar VJ, Lella A, Alkemade A, Bach Cuadra M, Barbeau EJ, Felician O, Pergola G, Pitel AL, Saranathan M, Tourdias T, Hornberger M. A roadmap towards standardized neuroimaging approaches for human thalamic nuclei. Nat Rev Neurosci. 2024 Dec; 25(12):792-808.